Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency

Clinical trial NCT05593588 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05593588
Sponsor: Avni Joshi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Common Variable Immunodeficiency Interstitial Lung Disease Due to Systemic Disease

Start date: 2023-04-12
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.